G protein-coupled receptors transmit extracellular signals into the cells by activating heterotrimeric G proteins, a process that is often followed by receptor desensitization.
amino acids, lipids, catecholamines, peptides or proteins to transmit information inside the cells by activating heterotrimeric G proteins formed by various α, β and γ subunits (Bockaert and Pin, 1999) . However, the detailed analysis of GPCRs and G protein activation in living cells is still limited. Within the last few years, energy transfer technologies (FRET and BRET) were shown to enable such an analysis allowing to monitor the physical proximity between various partners of a GPCR signaling cascade: the receptor, G protein subunits and their effectors (Azpiazu and Gautam, 2004; Bunemann et al., 2003; Dowal et al., 2006; Frank et al., 2005; Galés et al., 2005; Galés et al., 2006; Hein et al., 2005; Janetopoulos et al., 2001; Nobles et al., 2005; Rebois et al., 2006; Yi et al., 2003) . Agonist-promoted energy transfer changes has often been taken as the major indicator of either the association/dissociation of proteins or the transition from the inactive to active state of proteins. Indeed, while some authors linked the agonist-induced decrease of energy transfer signals with the reversible dissociation between G protein subunits (Azpiazu and Gautam, 2004; Janetopoulos et al., 2001; Yi et al., 2003) , others proposed, in contrast, that no molecular dissociation occurred between α, β and γ subunits after receptor activation and the decrease in energy transfer signals reflects molecular rearrangements and conformational changes within the αβγ heterotrimer Galés et al., 2006) . Likewise, for the interaction between GPCRs and G proteins, some data are consistent with the association-dissociation model and the absence of receptor-G protein "pre-association" or "pre-assembly" (Hein et al., 2005) , while others support a pre-assembly and agonist-induced conformational changes of pre-assembled GPCRs-G proteins complexes (Galés et al., 2005; Galés et al., 2006; Nobles et al., 2005) .
Protease-activated receptors (PARs) are a family of 4 different receptors that are activated by various proteases (Hollenberg and Compton, 2002; Macfarlane et al., 2001) .
PAR1, PAR3 and PAR4 respond to highly selective group of serine proteases that include thrombin, plasmin, the factor Xa and the activated protein C (Cottrell et al., 2002; Macfarlane et al., 2001) . In contrast, PAR2 receptor can be activated by trypsin, tryptase and the coagulation factors VIIa and Xa (Macfarlane et al., 2001; Cottrell et al., 2002; Myatt and Hill, 2005) . The activation mechanism of these receptors involved the cleavage of their N-terminal segment by the protease, unmasking a new N-terminus that acts as a tethered ligand, directly activating the transmembrane core of the receptor (Coughlin, 1999) . Of interest, PARs can also be activated by synthetic peptides that mimic the tethered ligand, without the requirement of protease cleavage of receptors (Al-Ani et al., 2002; Chen et al., 1994; Vu et al., 1991) .
Such an activation mechanism leads to the constitutive activation of the receptor by proteases, followed by the rapid desensitization, internalization and degradation of the cleaved receptor (Chen et al., 2004; Cottrell et al., 2002; Trejo, 2003) . This desensitization process involved the well characterized phosphorylation of the receptor by GRKs and the recruitment of arrestins (Paing et al., 2002; Trejo, 2003) . PARs are involved in a number of physiological processes such as, thrombosis (Chung et al., 2002) , vascular biology (Barnes et al., 2004) , inflammation (Kannan, 2002) and the regulation of cell proliferation and tumorigenesis (Boire et al., 2005) and represent important new targets for the treatment of a number of pathologies.
In the present study, we used a BRET approach to monitor the coupling between PAR1 and G αi1 protein in living COS-7 cells. Our data show that PAR1 receptor activation using either thrombin or agonist peptides mimicking the tethered ligands lead to a rapid, but transient, increase in the BRET signal measured between the receptor fused to YFP, and G αi1 fused to Rluc. The desensitization kinetic of this response is similar to that of the recruitment of ß-arrestin-1 to the receptor, indicating that the observed signal reflects the G protein activation in living cells. Of interest, our data also revealed a close proximity between the inactive receptor and the G αi1 protein consistent with their possible pre-assembly. Similar strategy has been followed for the truncation of the N-terminus (PAR1-∆N-YFP) and
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the deletion of the C-terminus (PAR1-∆C-YFP) of PAR1 using the BamHI cloning site. For all these constructs, the junction sequence between PARs and YFP was similar coding for ten residues (YRDPRVPVAT).
For G αi1 -Rluc fusion protein, site-directed mutagenesis was first performed on the cDNA of the human G αi1 to insert an EcoRI site between position encoding isoleucine 93 and aspartic acid 94 within the helical domain of the G protein (see Fig.11C ). Then, the intermediate construct (G αi1 -EcoRI) was used to insert at the EcoRI site the coding region of the Renilla luciferase enzyme (Rluc) without stop codon and bearing the glycine rich-linker sequences coding for Gly-Asn-Ser-Gly-Gly in the 5' end and Gly-Gly-Gly-Asn-Ser in the 3' end, respectively. The PCR product of Rluc was inserted in phase between EcoRI site of G αi1 -EcoRI plasmid. For G αs -Rluc construct, the fusion was performed between alanine 188 and aspartic acid 189 using NheI site with glycine rich-linker similar to that used for G αi1 -Rluc.
For Flag-PAR1-YFP construct, the MluI/HindIII fragment of PAR1-YFP obtained by PCR was inserted between MluI and HindIII into pRK5-Flag-GABAb1 containing the mGluR5 signal peptide to allow its expression and targeting to the cell surface. All constructs were verified by sequencing and their expression in COS-7 cells was confirmed by luminescence, fluorescence and western blot.
Cell culture and transfection: COS-7 cells were grown in complete medium (DMEM supplemented with 10 % (v/v) FBS, 4.5 g/l glucose, 100 U/ml penicillin, 0.1 mg/ml streptomycin, 1 mM glutamine)(all from Life Technologies (Gaithersburg, MD)). Transient transfections were performed using electroporation as described previously (Brabet et al., 1998) . 
Microplate BRET assay and Kinetics analysis
Inositol phoshate measurements:
The determination of the inositol phosphate 1 accumulation in COS-7 cells was performed in 96-wells microplates using the HTRF ® -IP-One kit (CisBio International). Briefly, cells were stimulated 30 minutes at 37°C with thrombin in the stimulation buffer pH 7.4: HEPES 10 mM, CaCl 2 1 mM, MgCl 2 0.5 mM, KCl 4.2 mM, NaCl 146 mM, glucose 5.5 mM, LiCl 50 mM pH 7.4. The reaction was stopped by 50 mM phosphate buffer, pH 7.0, 1 M KF and 1% Triton X-100 containing HTRF® assay reagents:
the Europium Cryptate-labeled anti-IP1 antibody and d2-labeled IP1. The assay was incubated overnight at 4°C and TR-FRET signal were measured 50 µs after excitation at 620 nm and 665 nm using a RubyStar instrument.
ELISA: Twenty-four hours post-transfection, COS-7 cells were fixed 5 minutes at room temperature with 4% of paraformaldehyde and permeabilized or not 5 minutes with 0.05% Triton X-100. Cells were then blocked with phosphate-buffered saline containing 1% fetal calf serum, incubated 30 minutes at room temperature with 1 µg/ml of monoclonal anti-PAR1 or anti-Flag M2 antibodies. After washing steps, cells were incubated 30 minutes with 0.5 µg/ml of HRP-coupled anti-mouse secondary antibody (Amersham Pharmacia) and washed again. Bound antibody was detected using a SuperSignal substrate (Pierce, Rockford, IL) and
a Mithras LB 940 plate reader.
Luciferase gene reporter assay: COS-7 cells were transfected with the serum-response element-luciferase gene reporter (SRE-Luc) and PAR1 receptors, washed with PBS and switched to serum-free DMEM overnight. Cells were then treated or not with ligands for six hours in the serum-free DMEM at 37°C, washed with PBS and lysed with the reagent containing the luciferase substrate (Promega Bright-Glo™ Luciferase Assay System).
Luminescence was measured immediately using the Mithras LB 940 instrument.
Ligand Binding Assay:
Ligand binding assay was performed as previously described (Galvez et al., 2001) with 40000 cells/well and using the radiolabled GABAb receptor antagonist, Western blotting: COS-7 cells transfected or not with G αi1 or G αi1 -Rluc were lysed in Laemmeli buffer (125 mM Tris-HCl, pH 6.8, 4% sodium dodecyl sulfate (SDS), 20% glycerol, 0.01% bromophenol blue) and warmed 5 minutes at 90°C. Samples were then resolved by 10% SDS-polyacrylamide gel electrophoresis, transferred to nitrocellulose membrane (Amersham Pharmacia) and subjected to immunoblotting using a polyclonal rabbit anti-G αi1/2 antibody (Lledo et al., 1992) . Immunoreactive bands were visualized by the ECL detection Kit (Amersham Pharmacia) on Kodak ML light films.
Confocal imaging: COS-7 cells transiently expressing PAR1-YFP were fixed 5 minutes at room temperature with 4% of paraformaldehyde and washed with PBS. Cover slips were then mounted with Gel/Mount (Biomeda, Foster City, CA) and microscopic observations were performed on an Leica SP2 UV confocal microscope with a Plan-Apochromat 63x/1.4 oil objective with the appropriate YFP spectrums sittings.
Statistical analysis:
Two-way ANOVA test associated to Bonferroni post-test (GraphPad Prism software) was used to determine statistically significant differences between control (in the absence of ligands) and stimulated conditions.
RESULTS
Protease-activated receptor type 1 (PAR1) and G αi1 protein fused to energy acceptor and donor proteins. To monitor the coupling of PAR1 to G αi1 protein using a BRET approach, these two proteins were fused with the energy acceptor yellow fluorescent protein (YFP) and the energy donor luciferase from Renilla reniformis (Rluc), respectively (Fig. 1A) . The YFP was fused at the C-terminus of PAR1 and this did not alter its expression at the cell surface as shown by confocal microscopy (Fig. 1B) or ELISA assay with the anti-PAR1 antibody (Fig.   1C ) showing that the majority of receptors is expressed on the cell surface. Functional analysis showed that PAR1-YFP activated signaling pathways in similar way than the wildtype receptor, as monitored by the inositol phosphate production ( Fig. 1D ), luciferase gene reporter and cAMP assays (data not shown). Thrombin potency measured on cells expressing PAR1-YFP (EC 50 = 1 ± 0.4 nM, n=3) was similar to that measured on cell expressing PAR1 (EC 50 = 1.68 ± 1.3 nM, n=3).
The G αi1 -Rluc was obtained by inserting Rluc within the helical domain of the G αi1 protein between Ile 93 and Asp 94 residues. Such a position was chosen based on the crystal structure of the Gαßγ heterotrimeric complex, and was already used in many other studies with either G αi Frank et al., 2005; Galés et al., 2006) , G αs (Hynes et al., 2004; Yi et al., 2003) or G αo (Azpiazu and Gautam, 2004; Nobles et al., 2005) . In all cases, these fusion G proteins were shown to be correctly expressed and to allow an efficient coupling of receptors to their effectors. Indeed, like G αi1 (∼ 43 kDa) our G αi1 -Rluc is correctly expressed at the expected molecular weight (∼ 78 kDa) as shown by western blot using the antibody that recognizes G αi1 as well as G αi2 subunits (Fig. 1E ) and by luminescence measurements (Fig. 2C) . Note that the G αi1 -Rluc expression level is close to that of the endogenous proteins. The functionality of G αi1 -Rluc construct is illustrated by its ability to potentiate the inhibition of forskolin-stimulated cAMP production mediated by PAR1-YFP in a PTX-sensitive manner (Fig. 1F ). Such a potentiation did not result from an increased expression level of PAR1 at the cell surface in the presence of the co-transfected G-protein, as shown using an ELISA assay performed on intact cells using a PAR1 antibody (data not shown). In addition, the co-expression of G αi1 -Rluc with PAR1-YFP ( Fig. 1G) , lysophosphatidic acid or GABAb (data not shown) receptors largely enhanced agonistinduced inhibition of cAMP production.
Monitoring PAR1-G αi1 proximity in living cells by BRET. In cells co-expressing PAR1-YFP and G αi1 -Rluc, a significant basal BRET signal was detected compared to cells coexpressing G αs -Rluc and PAR1-YFP or V2-YFP ( Fig. 2A and B ). When cells were treated with thrombin (50 U/ml ≈ 15 µM), the BRET signal significantly increased between PAR1-YFP and G αi1 -Rluc but not G αs -Rluc ( Fig. 2A) . In contrast, the BRET between G αs -Rluc and V2-YFP can be specifically increased after cell stimulation with vasopressin (1 µM) ( Fig.   2B ). These differences in the basal BRET signal and the sensitivity to receptor activation between G αi1 -Rluc and G αs -Rluc were not due to the difference in the expression level of BRET partners quantified by luminescence and fluorescence measurements (Fig. 2C ). These results are compatible with the coupling properties of PAR1 and V2 receptors illustrated in Fig. 1F , since PAR1 is known to activate G αi1 but not G αs and inversely for V2.
The specificity of the basal and the protease-induced BRET signal. To demonstrate the specificity of both the basal and agonist-induced BRET signal, we performed BRETsaturation assay previously developed to demonstrate the specificity of protein-protein interactions (Ayoub et al., 2004; Mercier et al., 2002) . Indeed, when the amount of G αi1 -Rluc was maintained constant, increasing the amount of PAR1-YFP leads to an increase in the BRET ratio that reaches a plateau (Fig. 3A ). This plateau likely corresponds to the situation where all G αi1 -Rluc proteins available are specifically "pre-assembled" with available PAR1-YFP. Of interest, activation of the receptor leads to an increase in the maximal saturated BRET, consistent with a change in the energy transfer efficiency, rather than to the recruitment of additional G proteins in the vicinity of the receptor.
The specificity of the energy transfer was also verified by the BRET-competition assay (Ayoub et al., 2002) . The constitutive and thrombin-promoted BRET signals between PAR1-YFP and "non-saturating" amount of G αi1 -Rluc can be decreased by the co-expression of the untagged G αi1 protein (Fig. 3B ). This was not due to the change in the acceptor/donor (YFP/Rluc) ratio controlled by measuring both luminescence (Rluc signal) and fluorescence (YFP signal) signals (Fig. 3C ). This further confirms that the amount of G αi1 proteins in the vicinity of the receptor is saturable.
Quantification of PAR1 expression at the cell surface.
To determine the number of PAR1 receptors at the cell surface, we used a Flag-PAR1-YFP construct that possesses a Flag epitope inserted at the N-terminus. This receptor was shown to share the same functional properties as the wild-type PAR1 in terms of its ability to activate the inositol phosphate formation (data not shown). ELISA assay revealed that the receptor is correctly targeted to the cell surface ( Fig. 4A) . By comparing the ELISA signal with Flag-PAR1-YFP with that measured with a Flag-GABAb receptor for which the exact expression level can be determined by binding studies on intact cells with a non-permeable radioligand (Fig. 4B ), we calculated an expression of about 100,000 Flag-PAR1-YFP receptors per COS-7 cell.
Fluorescence measurements indicate that Flag-PAR1-YFP receptor expression is 5 times lower than the PAR1-YFP under similar transfection conditions ( Fig. 4C) , such that the measured basal BRET between Flag-PAR1-YFP and G αi1 -Rluc is also lower (Fig. 4D ), but still within the BRET saturation curve as indicated by the corresponding YFP/Rluc ratio (Fig.   3A ).
Real-time analysis of PAR1-G αi1 association and desensitization. Kinetic analysis showed that thrombin-induced BRET increase between G αi1 -Rluc and PAR1-YFP occurred rapidly (t 1/2 = 4.3 ± 0.6 s, n=13) ( Fig. 5A ). This increase persists few minutes and returns to the basal signal 15 minutes after protease application ( Fig. 5B ), consistent with known PAR1 desensitization properties (Trejo, 2003) . Indeed, when the signal was measured after preincubation 30 minutes with thrombin, no BRET increase was observed ( Fig. 5C ). Of interest, this decrease in agonist-induced BRET is concomitant with the recruitment of ß-arrestin1 to PAR1 also monitored by BRET. Indeed, thrombin application induced a BRET increase between Rluc-ß-arrestin-1 and PAR1-YFP in a dose-dependent manner with a potency (EC 50 = 2 ± 0.3 nM, n=3) similar to that determined in other functional assays (Fig. 6A) . Moreover, kinetic analysis shows that t 1/2 value of the recruitment of ß-arrestin-1 (5.4 ± 0.9 min, n=5) ( Fig. 6B) is compatible with that of the decay phase of agonist-induced BRET between G αi1 -Rluc and PAR1-YFP (t 1/2 = 6.9 ± 1.7 min, n=8, assuming a mono-exponential decay) ( Fig.   5B ). These data demonstrate that a fast and reversible process is involved in the increase in BRET between PAR1 and G αi1 resulting from receptor activation and the activation/desensitization processes of PAR1 can be studied by BRET.
PARs activation is responsible for the increase in the BRET signal. Several lines of evidence indicate that thrombin-induced BRET increase results from PAR1 activation. First, when using a trypsin-activated PAR2 receptor (Coughlin, 2000; Macfarlane et al., 2001) fused to YFP instead of PAR1, a similar basal BRET was measured with G αi1 -Rluc that is increased after trypsin (100 nM) but not thrombin stimulation (Fig. 7A ). Second, thrombin ( Fig. 7B) and trypsin (Fig. 7C ) effects on PAR1 and PAR2, respectively, were dose-dependent with EC 50 values (6.3 ± 0.2 nM, n=17 and 1.3 ± 0.3 nM, n=3, respectively) comparable to potencies reported for these proteases on PARs (Al-Ani et al., 2002; Boire et al., 2005; O'Brien et al., 2000) . Third, peptides known to mimic the activating N-terminal end of PARs after their cleavage by proteases increased the BRET signal. This was obtained either with the non-selective PAR-activating peptide TRAP-14 (100 µM) (Debeir et al., 1996) or with the PAR1-selective (TFLLR, 100 µM) (Chung et al., 2002) agonist peptides on PAR1 expressing cells (Fig. 8A) . The PAR2-selective peptide (SLIGRL, 100 µM)(Al-Ani et al., 2002) had no effect on PAR1 expressing cells ( Fig. 8A ) but it was active on PAR2 expressing cells (data not shown). The TFLLR-induced BRET increase was dose-dependent with an EC 50 value of 5.8 ± 1.9 µM (n=8) in agreement with its reported potency on PAR1 (Fig. 8B ) (Seeley et al., 2003) . Like for thrombin, kinetics analysis shows that peptide-induced BRET increase occurs rapidly (t 1/2 = 6.5 ± 1.5 s, n=5) ( Fig. 8C ). Similar effect of the PAR1-selective peptide was observed when PAR1 was deleted of its N-terminal end containing the tethered ligand (PAR1-∆N-YFP) ( Fig. 8D ) and making the receptor insensitive to thrombin ( Fig. 8E and F) .
Finally, both protease inhibitors ( Fig. 9A ) and the PAR1 selective non-peptidic antagonist SCH79797 (10 µM) ( Fig. 9B ) completely abolished the agonist-promoted BRET increase without affecting the basal BRET signal.
Agonist-induced BRET increase is associated to G αi1 activation. We next examined whether the basal and agonist-induced BRET result from G protein activation. Inactivating G αi1 -Rluc with Pertussis toxin (PTX, 100 ng/ml) ( Fig. 10 ) suppressed agonist-induced BRET, but not the basal signal. This demonstrates that the basal BRET measured in the absence of PAR1 activation does not results from G protein activation. Moreover, these data reveal that the mode of interaction or assembly between G αi1 and PAR1 (the distance and/or the relative orientation of Rluc and YFP fused to G αi1 and PAR1, respectively) is likely different whether the receptor is in its inactive or active state.
Movement within the pre-assembled PAR1-G αi1 complexes represents the major cause of the agonist-induced BRET increase. To get more insights in the molecular events leading to BRET increase after receptor activation, similar experiments were conducted with a receptor in which the YFP was inserted at a different site, closer to the helix 8 (PAR1-∆C-YFP) (Fig.   11A ). Indeed, if the increase in BRET resulting from receptor activation is due to the recruitment of additional G αi1 protein in the close vicinity of the receptor, this should be observed whatever the YFP position on the receptor. Such a deletion completely abolished the agonist-induced recruitment of ß-arrestin1 but not its ability to activate G proteins (data not shown). A high basal BRET signal was measured between PAR1-∆C-YFP and G αi1 -Rluc, but the activation of this mutant with either thrombin or TFLLR did not lead to any change in the BRET signal ( Fig. 11B ).
We also examined the influence of the Rluc position in G αi1 protein on the basal and agonist-induced BRET. For this reason, we used a G αi1 fusion protein in which Rluc was inserted at position Ala121-Glu122 in the helical-rich domain (G αi1 -122-Rluc) (Galés et al., 2006) . In this construct, the Rluc is positioned on the other side of the G protein compared to G αi1 -Rluc used so far in our study (Fig. 11C ). As shown in Fig. 11D , a larger basal BRET is observed with both PAR1-YFP and PAR1-∆C-YFP and G αi1 -122-Rluc compared to G αi1 -Rluc (Fig. 11B ), and this despite a similar expression level of all partners (data not shown).
However, no further increase in BRET was observed upon activation of the receptors with either thrombin or TFLLR (Fig. 11D ). Taken together, these data clearly dissociate the BRET increase from the recruitment of the G protein by the activated receptor and support the proposal that PAR1 and G αi1 are pre-assembled, and that receptor activation lead to a change in the positioning of the G αi1 subunit relative to the receptor (Fig. 12 ).
DISCUSSION
The application of energy transfer-based assays to study the interaction between GPCRs and their cognate G proteins constitutes an attractive field of research in GPCRs biology. Here, we monitored the physical proximity between PAR1 and G αi1 protein using a BRET approach in living COS-7 cells. Our data show that the kinetic of BRET changes resulting from PAR1 receptor activation is consistent with the fast activation process, and the known desensitization properties of these receptors. These data further indicate that BRET signals measured between the receptor and G protein can be used to monitor GPCRs activation and desensitization in real time and in living cells.
Our data first revealed a significant basal BRET signal between PARs-YFP (PAR1 and PAR2) and G αi1 -Rluc. This basal BRET is specific since it was not observed with G αs -Rluc, in agreement with the known coupling properties of PARs (Coughlin, 2000; Macfarlane et al., 2001) , and is saturable as shown by the BRET-saturation experiment and the displacement by the "unlabeled" G αi1 protein. Moreover, such a basal BRET is measured with G αi1 -Rluc expression level similar to that of endogenous G αi1 , and is observed for receptor expression level at the cell surface of about 100,000 receptors per COS-7 cell. This is consistent with the known physiological expression of PAR1 in platelets (about 1,000 receptors per platelet (Brass et al., 1992; Norton et al., 1993) , corresponding to 100,000 receptors per COS-7 cell assuming the later is 10 times larger in diameter).
Recent studies using BRET or FRET approaches also reported a constitutive energy transfer between GPCRs and G proteins (Azpiazu and Gautam, 2004; Bunemann et al., 2003; Frank et al., 2005; Galés et al., 2005; Galés et al., 2006; Hein et al., 2005; Janetopoulos et al., 2001; Nobles et al., 2005; Yi et al., 2003) . The authors propose that this is due either to the existence of a "pre-associated" or "pre-assembled" receptor-G protein complexes, or to the constitutive activity of the GPCR. Our data do not support that the basal BRET signal results from any possible constitutive activation of G αi1 by PARs. Indeed, there is so far no evidence for the constitutive activity of PARs including in our expression system (data not shown).. Such a close proximity suggests a direct interaction between these partners. However, despite major efforts we have not been able to observe co-immunoprecipitation of PARs and G αi1
Moreover
protein. Although the direct interaction between PARs and G αi1 is a likely explanation, our data may also well be explained by a co-localization of both partners in specific small microdomains ( Fig. 12) . Indeed, recent studies using single-molecule tracking reported that GPCR diffusion is restricted to small microdomains that may be limited by specific fences under the plasma membrane Suzuki et al., 2005) , or may possibly correspond to caveolae or lipid raft (Insel et al., 2005; Meyer et al., 2006) . If the G proteins are also incorporated into such microdomains, this will likely result in a limited number of G proteins in the close vicinity of the receptor, consistent with a saturable basal BRET signal observed. Moreover, the likely high density of both receptors and G proteins in such microdomains (Insel et al., 2005) may favor energy transfer between Rluc and YFP fused to these partners. Other recent study by BRET and bimolecular fluorescence complementation approaches reported that receptors and G proteins complexes are formed early during proteins biosynthesis , such that part of the basal BRET observed likely reflect such pre-formed intracellular complexes. However, we would like to point out that the basal BRET cannot result solely from intracellular complexes, as demonstrated by the BRET saturation experiment shown in Fig. 3A . The proportion of intracellular receptors is expected to increase when receptor expression levels reach saturation. If the basal BRET only reflects intracellular complexes, then the basal BRET value relative to the agonist-induced BRET value should largely increase with receptor expression. This is clearly not the case.
Our second main observation is that PAR1 activation using either thrombin or peptides mimicking the tethered ligand leads to a rapid increase in the BRET signal measured between the receptor and G αi1 . These effects were specific of the receptor-protease/peptide pair. Moreover, the BRET increase was completely prevented by protease inhibitors, PAR1
antagonist and PTX indicating that agonist-induced BRET increase reflects the activation of receptor-G protein complexes. The agonist-induced BRET increase between G αi1 -Rluc and PAR1-YFP was found to be rapid, in agreement with the rapid activation of G proteins by other GPCRs Galés et al., 2005; Galés et al., 2006) and consistent with what is expected for such a process. Our kinetic analysis revealed a t 1/2 of about 5 seconds when using saturating concentrations of thrombin, a process that appears slower than that reported for G αi activation by the α 2 -adrenergic receptor using either BRET (Galés et al., 2005; Galés et al., 2006) or FRET (Hein et al., 2005) . This may well result from differences in the activation kinetic between different GPCRs, as observed between the PTH and α 2adrenergic receptors (Vilardaga et al., 2003) .
Further evidence that ligand-induced BRET increase results from G protein activation comes from the reversibility of this effect, consistent with the well known PAR1 receptor desensitization (Trejo, 2003) . Indeed, our data revealed that the agonist-induced BRET was largely decreased after 10 minutes and disappeared after 30 minutes, a kinetic that nicely fits with that of thrombin-induced β-arrestin-1 recruitment also monitored by BRET.
This data clearly indicates that agonist-induced BRET increase, but not the basal signal, is associated to PAR1 and G αi1 protein activation and further confirms the role of ß-arrestin-1 in G protein uncoupling and PAR1 desensitization.
Two possibilities can explain the increase in BRET ratio observed between PARs and G αi1 protein after activation: 1) additional recruitment of G αi1 protein by the active form of the receptor or 2) a change in the relative positioning of the fused YFP and Rluc within the pre-assembled receptors and G proteins (Fig. 12 ). Our data are not consistent with the additional recruitment of G αi1 proteins in the pre-assembled complexes. Indeed, when increasing the amount of PAR1-YFP fusion protein with a constant amount of G αi1 -Rluc, a saturation limit in the basal BRET signal is observed suggesting that all receptors are preassembled with the G protein under these conditions. Upon receptor activation, this maximal BRET value is increased. This is consistent with a better efficacy in the energy transfer within the pre-assembled receptor-G protein complex after activation, rather than an increase in the number of G proteins interacting with the receptor. Accordingly, the increase in BRET signal observed after receptor activation likely results from a relative movement of the fused Rluc and YFP in the pre-assembled complexes. This proposal is also supported by the differential sensitivity to PTX treatment of the basal and agonist-induced BRET. Because a direct interaction between the C-terminal tail of G αi1 protein (the target of PTX), and the second and third intracellular loops of the receptor is known to occur during activation (Bourne, 1997) , this further indicates that G αi1 and PAR1 interacts in a specific manner with the active form of the receptor. Moreover, the movement hypothesis is supported by the fact that the agonistinduced BRET change largely depends on the relative positioning of the Rluc and YFP in the G protein and the receptor, respectively. Indeed, the agonist-induced BRET increase is completely abolished when the YFP is fused closer to the helix 8 of PAR1 (in agreement with the expected movement of the C-terminal tail of the receptor during activation) (Fig. 11B) , and is not observed if Rluc is inserted on the other side of the G αi1 protein (Fig. 11C and D) .
This would not be expected if the increase in BRET simply results from G protein recruitment in the vicinity of the activated receptor.
Taken together, our data are consistent with a pre-assembly between G αi1 protein and PARs, and their relative movement occurring after receptor activation. Whether such a pre-assembly results from a direct interaction of PARs and the G protein, or their colocalization in small and saturable membrane microdomains remains to be further studied.
Whatever, this is compatible with recent studies reporting the existence of pre-assembled complexes between receptors, G proteins and effectors (Galés et al., 2005; Nobles et al., 2005; Galés et al., 2006; Rebois et al., 2006; Dowal et al., 2006) . All these studies proposed that energy transfer changes reflect conformational changes within the pre-associated complexes rather than receptor activation-promoted association. This suggests that the assembly of GPCRs, G proteins and effectors does not represent a limiting step in the activation process and further documents the hypothesis that these partners can be part of pre-assembled protein complexes responsible for GPCRs-mediated signaling, offering the way to a higher selectivity and a faster process. MOL #30304
